Economics and capital · Exits liquidity
Iambic Therapeutics Plans Eight-Hundred-Million-Dollar IPO
NVIDIA-backed Iambic Therapeutics is planning a Nasdaq IPO targeting a valuation above $800 million and potentially raising $159.4 million.
Read the original at finimize.comOpens the publisher's site in a new tab